Other Income/Expenses (Net)

$144.90M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$144.90Mperiod endingJun 30, 2026

VRTX Quarterly Other Income/Expenses (Net) (-$500.00K → $144.90M)

Quarterly Other Income/Expenses (Net)

High-resolution chart · PNG

VRTX other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Other Income/Expenses (Net) — Quarterly (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	5,341,000
Mar 31, 2001	0
Dec 31, 2000	-157,000
Sep 30, 2000	-14,792,000
Jun 30, 2000	5,000
Mar 31, 2000	-621,000
Dec 31, 1999	-100,000
Sep 30, 1999	2,300,000
Jun 30, 1999	2,478,000
Mar 31, 1999	3,100,000
Dec 31, 1998	0
Sep 30, 1998	0
Jun 30, 1998	0
Mar 31, 1998	4,000,000
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	1,800,000
Sep 30, 1996	1,200,000
Jun 30, 1996	-14,000,000
Mar 31, 1996	1,300,000
Dec 31, 1995	1,600,000
Sep 30, 1995	1,200,000
Jun 30, 1995	1,400,000
Mar 31, 1995	1,300,000
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	400,000
Sep 30, 1993	300,000
Jun 30, 1993	400,000
Mar 31, 1993	300,000
Dec 31, 1992	400,000
Sep 30, 1992	500,000
Jun 30, 1992	500,000
Mar 31, 1992	600,000
Dec 31, 1991	400,000
Sep 30, 1991	300,000
Jun 30, 1991	100,000
Mar 31, 1991	-800,000
Dec 31, 1990	5,800,000
Sep 30, 1990	-600,000
Jun 30, 1990	-600,000
Mar 31, 1990	-500,000